Iclaben Cream contains Luliconazole 1% w/w, a topical antifungal agent indicated for the treatment of superficial dermatophytic infections such as tinea corporis, tinea cruris, and tinea pedis. Luliconazole belongs to the imidazole class of antifungals and exerts its effect by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. Iclaben Cream is effective against a broad spectrum of dermatophytes and yeasts, including Trichophyton species and Candida albicans. The cream formulation facilitates easy application and enhanced skin penetration, ensuring targeted delivery to the affected area. It is typically applied once daily to the affected skin after cleansing and drying, with treatment duration varying depending on the infection type and severity, generally ranging from one to two weeks. Patients should avoid contact with eyes and mucous membranes and discontinue use if irritation or hypersensitivity occurs. Iclaben Cream is contraindicated in individuals with known hypersensitivity to luliconazole or any cream excipients. This medication provides an effective and convenient option for managing superficial fungal infections, promoting symptom resolution and preventing recurrence when used as directed.